Medical College of Wisconsin Cancer Center
Showing 1 - 25 of >10,000
Metastatic Pancreatic Cancer Trial in United States (NEAAR Medical Food)
Recruiting
- Metastatic Pancreatic Cancer
- NEAAR Medical Food
-
Tucson, Arizona
- +10 more
Jan 11, 2023
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Not yet recruiting
- Non Hodgkin Lymphoma
- Long-term Follow-Up
-
Stanford, California
- +4 more
Oct 30, 2023
Diffuse Large B Cell Lymphoma, DLBCL, Cancer Trial in Madison (Rituximab, Cyclophosphamide, Doxorubicin)
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
- Rituximab
- +5 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Dec 12, 2022
Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )
Breast Tumors Trial in United States (endocrine therapy alone without radiotherapy)
Active, not recruiting
- Breast Neoplasms
- endocrine therapy alone without radiotherapy
-
Stanford, California
- +12 more
Dec 20, 2022
MCW Master Predict
Recruiting
- Cancer
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Apr 6, 2023
The Life After Stopping Tyrosine Kinase Inhibitors Study
Completed
- Leukemia, Myeloid, Chronic
- Imatinib (Stopping their TKI)
- +3 more
-
San Francisco, California
- +15 more
Jan 3, 2023
ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer Trial in Madison, Milwaukee (Onapristone, Fulvestrant)
Recruiting
- ER-positive Breast Cancer
- +2 more
-
Madison, Wisconsin
- +1 more
Jul 7, 2022
Relapsed or Refractory Multiple Myeloma Trial in Canada, United States (mRNA-2736)
Not yet recruiting
- Relapsed or Refractory Multiple Myeloma
- mRNA-2736
-
Birmingham, Alabama
- +12 more
Jun 15, 2023
Lung Nodule Trial in United States (CT-Guided Biopsy, Navigation bronchoscopy)
Recruiting
- Lung Nodule
- CT-Guided Biopsy
- Navigation bronchoscopy
-
San Diego, California
- +6 more
Dec 20, 2022
Metastatic Hormone-sensitive Prostate Cancer Trial in United States (androgen-deprivation therapy, docetaxel)
Active, not recruiting
- Metastatic Hormone-sensitive Prostate Cancer
- androgen-deprivation therapy
- docetaxel
-
Anchorage, Alaska
- +342 more
Jan 29, 2023
Breast Cancer Trial in United States (Selene)
Recruiting
- Breast Cancer
- Selene
-
Tampa, Florida
- +7 more
Oct 12, 2022
Multiple Myeloma, Relapse Multiple Myeloma Trial in Bethesda, Madison (Descartes-25)
Recruiting
- Multiple Myeloma
- Relapse Multiple Myeloma
-
Shreveport, Louisiana
- +3 more
Nov 4, 2022
Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v7 Trial in Canada, Israel,
Active, not recruiting
- Metastatic Renal Cell Carcinoma
- +4 more
- Nephrectomy
- +4 more
-
Birmingham, Alabama
- +414 more
Dec 30, 2022
Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)
Completed
- Breast Cancer
- Stage IV Breast Cancer
- palliative surgery
- +3 more
-
Mobile, Alabama
- +376 more
Jan 6, 2023
Metastatic Castration-resistant Prostate Cancer Trial in United States (REGN4336, Cemiplimab, 18F-DCFPyL)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- REGN4336
- +2 more
-
Palo Alto, California
- +8 more
Jan 17, 2023
Light Chain (AL) Amyloidosis Trial in New York (STI-6129)
Recruiting
- Light Chain (AL) Amyloidosis
- STI-6129
-
Duarte, California
- +3 more
Jan 12, 2023
Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8 Trial in United States (drug,
Recruiting
- Bladder Urothelial Carcinoma
- +3 more
- Atezolizumab
- +12 more
-
Phoenix, Arizona
- +320 more
Feb 2, 2023
Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage
Recruiting
- Basaloid Squamous Cell Carcinoma
- +7 more
- Cisplatin
- +5 more
-
Birmingham, Alabama
- +469 more
Jan 28, 2023
Liver Tumor, HCC, Metastasis Trial in United States (HistoSonics Histotripsy)
Recruiting
- Liver Tumor
- +2 more
- HistoSonics Histotripsy
-
Miami, Florida
- +7 more
Jan 3, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Non-Hodgkin Trial in Worldwide (LOXO-338,
Active, not recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +6 more
-
Duarte, California
- +8 more
Jan 11, 2023